Karyopharm Therapeutics (KPTI) Convertible Debt (2018 - 2024)
Karyopharm Therapeutics (KPTI) reported Convertible Debt of $171.13 million for Q1 2024, up 0.5% from $170.31 million a year earlier and up 0.1% from the prior quarter.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Convertible Debt (2018 - 2024) Analysis & Trends
At the end of FY2023, Karyopharm Therapeutics posted Convertible Debt of $170.92 million, up 0.5% from FY2022.
- Convertible Debt has increased for five consecutive years, with a five-year compound annual growth rate of 10.7% (FY2018 to FY2023).
- By year, Convertible Debt came in at $170.11 million in FY2022 (+0.5%), $169.29 million in FY2021 (+43.6%), $117.93 million in FY2020 (+7.3%) and $109.86 million in FY2019 (+7.0%).
- The Q1 2024 figure ranks as the highest quarterly Convertible Debt in data going back to Q4 2018.
- Year over year, Convertible Debt has now increased in each of the last 18 quarters, with growth averaging 0.5% over the last eight quarters.
- Across the past five years, year-over-year growth in Convertible Debt ran from 0.5% in Q1 2022 to 50.9% in Q1 2021.
- Per Business Quant data, the three quarters before Q1 2024 came in at $170.92 million (Q4 2023), $170.7 million (Q3 2023) and $170.5 million (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Karyopharm Therapeutics | 12.16 Mn | -214.27 Mn | 32.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 171.13 Mn |
| Dec 31, 2023 | 170.92 Mn |
| Sep 30, 2023 | 170.70 Mn |
| Jun 30, 2023 | 170.50 Mn |
| Mar 31, 2023 | 170.31 Mn |
| Dec 31, 2022 | 170.11 Mn |
| Sep 30, 2022 | 169.89 Mn |
| Jun 30, 2022 | 169.69 Mn |
| Mar 31, 2022 | 169.49 Mn |
| Dec 31, 2021 | 169.29 Mn |
| Sep 30, 2021 | 169.09 Mn |
| Jun 30, 2021 | 168.90 Mn |
| Mar 31, 2021 | 168.70 Mn |
| Dec 31, 2020 | 117.93 Mn |
| Sep 30, 2020 | 115.80 Mn |
| Jun 30, 2020 | 113.78 Mn |
| Mar 31, 2020 | 111.77 Mn |
| Dec 31, 2019 | 109.86 Mn |
| Sep 30, 2019 | 107.96 Mn |
| Jun 30, 2019 | 106.16 Mn |
API Access
Karyopharm Therapeutics Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();